Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Prevention of dementia using mobile phone applications (PRODEMOS): protocol for an international randomised controlled trial

Open access

Abstract

Introduction: Profiles of high risk for future dementia are well understood and are likely to concern mostly those in low-income and middle-income countries and people at greater disadvantage in high-income countries. Approximately 30%–40% of dementia cases have been estimated to be attributed to modifiable risk factors, including hypertension, smoking and sedentary lifestyle. Tailored interventions targeting these risk factors can potentially prevent or delay the onset of dementia. Mobile health (mHealth) improves accessibility of such prevention strategies in hard-to-reach populations while at the same time tailoring such approaches. In the current study, we will investigate the effectiveness and implementation of a coach-supported mHealth intervention, targeting dementia risk factors, to reduce dementia risk. Methods and analysis: The prevention of dementia using mobile phone applications (PRODEMOS) randomised controlled trial will follow an effectiveness–implementation hybrid design, taking place in the UK and China. People are eligible if they are 55–75 years old, of low socioeconomic status (UK) or from the general population (China); have ≥2 dementia risk factors; and own a smartphone. 2400 participants will be randomised to either a coach-supported, interactive mHealth platform, facilitating self-management of dementia risk factors, or a static control platform. The intervention and follow-up period will be 18 months. The primary effectiveness outcome is change in the previously validated Cardiovascular Risk Factors, Ageing and Incidence of Dementia dementia risk score. The main secondary outcomes include improvement of individual risk factors and cost-effectiveness. Implementation outcomes include acceptability, adoption, feasibility and sustainability of the intervention. Ethics and dissemination: The PRODEMOS trial is sponsored in the UK by the University of Cambridge and is granted ethical approval by the London—Brighton and Sussex Research Ethics Committee (reference: 20/LO/01440). In China, the trial is approved by the medical ethics committees of Capital Medical University, Beijing Tiantan Hospital, Beijing Geriatric Hospital, Chinese People’s Liberation Army General Hospital, Taishan Medical University and Xuanwu Hospital. Results will be published in a peer-reviewed journal. Trial registration number: ISRCTN15986016 .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2021-049762

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Overview of the prevention of dementia using mobile phone applications (PRODEMOS) platform and its functionalities. Main features of coach portal: viewing and adjusting details of goals and measurements; sending and receiving chat messages to and from the participants; sending education and news items. Main features of intervention app: setting and adjusting goals; entering measurements; sending and receiving chat messages to and from the coach; reading education and news items automatically pushed by platform or received from the coach; receiving periodic adverse event questionnaires and self-assessment questionnaires. Main features of assessor portal: blinded collection of participant data through electronic case report forms and questionnaires. The control application has similar connections with the assessor portal and the researcher portal/database, but is not connected to the coach portal.
Figure 1 Overview of the prevention of dementia using mobile phone applications (PRODEMOS) platform and its functionalities. Main features of coach portal: viewing and adjusting details of goals and measurements; sending and receiving chat messages to and from the participants; sending education and news items. Main features of intervention app: setting and adjusting goals; entering measurements; sending and receiving chat messages to and from the coach; reading education and news items automatically pushed by platform or received from the coach; receiving periodic adverse event questionnaires and self-assessment questionnaires. Main features of assessor portal: blinded collection of participant data through electronic case report forms and questionnaires. The control application has similar connections with the assessor portal and the researcher portal/database, but is not connected to the coach portal.CC BY · PubMed Central
Figure 2 Trial design. AE, adverse event; ISCED, International Standard Classification of Education; MMSE, Mini-Mental State Examination; RCT, randomised controlled trial.
Figure 2 Trial design. AE, adverse event; ISCED, International Standard Classification of Education; MMSE, Mini-Mental State Examination; RCT, randomised controlled trial.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 48 references

Cited by

See all 37

Metadata

Authors
Eggink, E., Hafdi, M., Hoevenaar-Blom, M. P., Song, M., Andrieu, S., Barnes, L. E., Birck, C., Brooks, R. L., Coley, N., Ford, E., Georges, J., van der Groep, A., van Gool, W. A., Handels, R., Hou, H., Li, D., Liu, H., Lyu, J., van Marwijk, H., van der Meijden, M., Niu, Y., Sadhwani, S., Wang, W., Wang, Y., Wimo, A., Ye, X., Yu, Y., Zeng, Q., Zhang, W., Wang, W., Brayne, C., Moll van Charante, E. P., & Richard, E.
Affiliations
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Department of Neurology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands
  • Edith Cowan University (AU)
  • Inserm (FR)
  • University of Cambridge (GB)
  • Alzheimer Europe (LU)
  • Brighton and Sussex Medical School (GB)
  • Vital Health Software, Ede, The Netherlands
  • Department of Public and Occupational Health, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands
  • Maastricht University Medical Centre (NL)
  • Shandong First Medical University (CN)
  • Beijing Neurosurgical Institute, Beijing, China
  • Beijing Geriatric Hospital (CN)
  • Department of Primary Care and Public Health, Brighton and Sussex Medical School, Brighton, UK
  • Chinese PLA General Hospital (CN)
  • Karolinska Institutet (SE)
  • Fuzhou Comvee Network & Technology Co., Ltd, Fuzhou, China
  • Capital Medical University (CN)
  • Department of General Practice, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands
  • Radboud University Nijmegen (NL)
Corresponding author
Richard, Edo
Venue
BMJ Open
Publisher
BMJ
Published
2021-06
Volume
11
Issue
6
Pages
e049762
ISSN
2044-6055 (ISSN-L)
OpenAlex
W3212878347
Cited by
37
References
48
Citations by year
2026: 6 · 2025: 6 · 2024: 7 · 2023: 11 · 2022: 6 · 2021: 1
FWCI
7.02
Type
journal article
Language
en
Open access
Locations
  • BMJ Open (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Brighton Repository (University of Brighton) (acceptedVersion, cc-by)
  • Australasian Journal of Paramedicine (acceptedVersion, cc-by)
  • Research Publications (Maastricht University) (acceptedVersion, cc-by)
  • Figshare (acceptedVersion, cc-by)
  • Pure Amsterdam UMC (acceptedVersion, cc-by)
  • Research Publications (Maastricht University) (acceptedVersion, other-oa)
  • HAL (submittedVersion, cc-by)
  • Sussex Research Online (University of Sussex) (submittedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Australasian Journal of Paramedicine (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
  • Apollo (cc-by)
Funders
  • R&D (2017YFE0118800)
  • European Union (779238)
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
Keywords
dementia prevention, mobile health, mobile health intervention, dementia risk factors, cardiovascular risk factors, aging, self-management, low socioeconomic status, older adults, implementation outcomes, cost-effectiveness
MeSH terms
Aged, China, Dementia, Humans, London, Middle Aged, Randomized Controlled Trials as Topic, Cell Phone, Mobile Applications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevention of dementia using mobile phone applications (PRODEMOS): protocol for an international randomised controlled trial. https://app.cochat.ai/papers/10.1136/bmjopen-2021-049762
The paper
Eggink, E., Hafdi, M., Hoevenaar-Blom, M. P., Song, M., Andrieu, S., Barnes, L. E., Birck, C., Brooks, R. L., Coley, N., Ford, E., Georges, J., van der Groep, A., van Gool, W. A., Handels, R., Hou, H., Li, D., Liu, H., Lyu, J., van Marwijk, H., . . . Richard, E. (2021). Prevention of dementia using mobile phone applications (PRODEMOS): protocol for an international randomised controlled trial. BMJ Open. https://doi.org/10.1136/bmjopen-2021-049762

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.